Now live: Pro — the full 13F research suite for serious investorsSee pricing →
Atlas Venture Associates IX, LLC

Q1 2023 · 13F-HR

Atlas Venture Associates IX, LLCholdings as filed

Filed 2023-05-08 · accession 0001104659-23-057059

$21.3M
Reported value
6
Positions
2023-03-31
Period end
View analyzed profile →PRO

Holdings as filed

CUSIPTickerIssuerValue% port.SharesClassVoting
83067L109SKILLZ INC$13.5M63.5%22,909,859CommonSOLE
86877M209SURFACE ONCOLOGY INC$2.1M9.68%2,945,453CommonSOLE
84833T103SPROSPERO THERAPEUTICS INC$2.0M9.37%1,376,968CommonSOLE
83304A106SNAPSNAP INC$1.7M7.90%150,160CommonNONE
87166L100SYNLOGIC INC$1.7M7.84%2,651,963CommonSOLE
45826J105NTLAINTELLIA THERAPEUTICS INC$372,7001.75%10,000CommonSOLE

Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.